Showing results (251-260 of 400) with videos related to
Sort By:
Pageof 40
Pacing and Clinical Electrophysiology : PACE|February 6, 2013
Factors associated with improvement in utilization of cardiac resynchronization therapy in eligible heart failure patients: findings from IMPROVE HFAshish Shukla, Anne B Curtis, Mandeep R Mehra, et al.Journal of Cardiac Failure|May 28, 2021
Distribution and Correlates of Incident Heart Failure Risk in South Asian Americans: The MASALA StudyNilay S Shah, Anubha Agarwal, Mark D Huffman, et al.Journal of the American College of Cardiology|August 23, 2014
Clinical effectiveness of CRT and ICD therapy in heart failure patients by racial/ethnic classification: insights from the IMPROVE HF registryBoback Ziaeian, Yan Zhang, Nancy M Albert, et al.Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.Circulation|February 4, 2020
Advancing Healthcare Reform: The American Heart Association's 2020 Statement of Principles for Adequate, Accessible, and Affordable Health Care: A Presidential Advisory From the American Heart AssociationJohn J Warner, Ivor J Benjamin, Keith Churchwell, et al.Congestive Heart Failure (Greenwich, Conn.)|December 18, 2004
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseasesMarc A Silver, Alan Maisel, Clyde W Yancy, et al.Journal of the American College of Cardiology|April 26, 2008
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registryClyde W Yancy, William T Abraham, Nancy M Albert, et al.American Journal of Hypertension|September 27, 2018
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA StudyEhimare Akhabue, Thanh-Huyen T Vu, Anand Vaidya, et al.American Heart Journal|July 24, 2007
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)Barry H Greenberg, William T Abraham, Nancy M Albert, et al.American Heart Journal|February 16, 2010
Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)Nancy M Albert, Gregg C Fonarow, Clyde W Yancy, et al.Pageof 40